Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xiaojiean capsule for uterine fibroids (Qi stagnation, blood stasis and damp-heat syndrome)
ChiCTR2200059299Phase 4Not yet recruiting
- Sponsor
- Hebei University of Chinese Medicine
- Start
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Fibromyoma (LM) comparing Xiaojiean capsule with Placebo capsule (2 arms). Primary endpoint: Maximum rate of change in uterine fibroid volume at 3 menstrual cycles. Planned start Apr 2022; status: not yet recruiting.
02
Drugs
Xiaojiean
03
Conditions
Fibromyoma (LM)
Beyond the preview
Go deeper on ChiCTR2200059299.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200059299.